Andreas Fredenhagen

1.3k total citations
40 papers, 996 citations indexed

About

Andreas Fredenhagen is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Andreas Fredenhagen has authored 40 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Pharmacology and 8 papers in Organic Chemistry. Recurrent topics in Andreas Fredenhagen's work include Microbial Natural Products and Biosynthesis (15 papers), Cancer Treatment and Pharmacology (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Andreas Fredenhagen is often cited by papers focused on Microbial Natural Products and Biosynthesis (15 papers), Cancer Treatment and Pharmacology (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Andreas Fredenhagen collaborates with scholars based in Switzerland, Germany and Japan. Andreas Fredenhagen's co-authors include HEINRICH H. PETER, F. Märki, Paul Hug, Jan van Oostrum, R. Eggers, Hajime Komura, Urs Séquin, Helmut Mett, Koji Nakanishi and Ernst Gassmann and has published in prestigious journals such as Journal of the American Chemical Society, European Journal of Biochemistry and Tetrahedron.

In The Last Decade

Andreas Fredenhagen

39 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Fredenhagen Switzerland 20 456 288 224 128 100 40 996
JOSEPH A. MARQUEZ United States 16 432 0.9× 558 1.9× 193 0.9× 80 0.6× 117 1.2× 36 953
Jorge L. Galazzo United States 16 967 2.1× 434 1.5× 121 0.5× 149 1.2× 95 0.9× 26 1.6k
Luciano Gastaldo Italy 16 597 1.3× 445 1.5× 161 0.7× 74 0.6× 117 1.2× 24 941
F. Le Goffic France 19 420 0.9× 91 0.3× 282 1.3× 87 0.7× 73 0.7× 54 972
Juan F. González Spain 23 678 1.5× 182 0.6× 401 1.8× 196 1.5× 141 1.4× 69 1.5k
R. Krishna India 22 699 1.5× 136 0.5× 261 1.2× 54 0.4× 71 0.7× 83 1.1k
B. CAVALLERI Italy 19 424 0.9× 322 1.1× 330 1.5× 56 0.4× 87 0.9× 49 890
Anis Ahmad United States 21 375 0.8× 155 0.5× 451 2.0× 229 1.8× 56 0.6× 58 1.6k
Andrzej B. Hendrich Poland 20 778 1.7× 92 0.3× 166 0.7× 191 1.5× 32 0.3× 58 1.6k
Jieling Zhao United States 6 912 2.0× 149 0.5× 205 0.9× 52 0.4× 93 0.9× 7 1.7k

Countries citing papers authored by Andreas Fredenhagen

Since Specialization
Citations

This map shows the geographic impact of Andreas Fredenhagen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Fredenhagen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Fredenhagen more than expected).

Fields of papers citing papers by Andreas Fredenhagen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Fredenhagen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Fredenhagen. The network helps show where Andreas Fredenhagen may publish in the future.

Co-authorship network of co-authors of Andreas Fredenhagen

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Fredenhagen. A scholar is included among the top collaborators of Andreas Fredenhagen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Fredenhagen. Andreas Fredenhagen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murgasova, Renata, et al.. (2020). Non‐clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonist. Biopharmaceutics & Drug Disposition. 41(4-5). 166–183. 5 indexed citations
2.
Fredenhagen, Andreas, et al.. (2018). Gas-Phase Rearrangement of the O-Glucuronide of Vildagliptin Forms Product-Ion Fragments Suggesting Wrongly an N-Glucuronide. Drug Metabolism and Disposition. 47(3). 189–193. 1 indexed citations
4.
Fredenhagen, Andreas, et al.. (2006). Structure Determination of Neoefrapeptins A to N: Peptides with Insecticidal Activity Produced by the Fungus Geotrichum candidum. The Journal of Antibiotics. 59(5). 267–280. 27 indexed citations
5.
6.
Fredenhagen, Andreas & Rudolf Eggers. (2001). High pressure release of binary mixtures of CO2 and N2. Experimental investigation and simulation. Chemical Engineering Science. 56(16). 4879–4885. 12 indexed citations
7.
Fredenhagen, Andreas & Rudolf Eggers. (2000). Einfluss der Hydratbildung auf die Druckentlastung von feuchtem CO2. Chemie Ingenieur Technik. 72(10). 1221–1224. 2 indexed citations
8.
9.
Fredenhagen, Andreas, Frank Petersen, Marina Tintelnot‐Blomley, et al.. (1997). Semicochliodinol A and B: Inhibitors of HIV-1 Protease and EGF-R Protein Tyrosine Kinase Related to Asterriquinones Produced by the Fungus Chrysosporium merdarium.. The Journal of Antibiotics. 50(5). 395–401. 35 indexed citations
10.
Cai, Yang, Andreas Fredenhagen, Paul Hug, Thomas Meyer, & HEINRICH H. PETER. (1996). Further Minor Metabolites of Staurosporine Produced by a Streptomyces longisporofiavus Strain.. The Journal of Antibiotics. 49(6). 519–526. 19 indexed citations
11.
Fredenhagen, Andreas, Paul Hug, Hanspeter Sauter, & HEINRICH H. PETER. (1995). Paeciloquinones A,B,C,D,E and F: New Potent Inhibitors of Protein Tyrosine Kinase Produced by Paecilomyces carneus. II. Characterization and Structure Determination.. The Journal of Antibiotics. 48(3). 199–204. 19 indexed citations
13.
Cai, Yang, Andreas Fredenhagen, Paul Hug, & HEINRICH H. PETER. (1995). A Nitro Analogue of Staurosporine and Other Minor Metabolites Produced by a Streptomyces longisporoflavus Strain.. The Journal of Antibiotics. 48(2). 143–148. 20 indexed citations
14.
Fredenhagen, Andreas, Christof Angst, & HEINRICH H. PETER. (1995). Digestion of Rhizocticins to (Z)-L-2-amino-5-phosphono-3-pentenoic acid:Revision of the Absolute Configuration of Plumbemycins A and B.. The Journal of Antibiotics. 48(9). 1043–1045. 11 indexed citations
15.
Fredenhagen, Andreas, Helmut Mett, Thomas Meyer, et al.. (1995). Protein Tyrosine Kinase and Protein Kinase C Inhibition by Fungal Anthraquinones Related to Emodin.. The Journal of Antibiotics. 48(11). 1355–1358. 27 indexed citations
16.
Zimmermann, Norbert, Stefan M.V. Freund, Andreas Fredenhagen, & Günther Jung. (1993). Solution structures of the lantibiotics duramycin B and C. European Journal of Biochemistry. 216(2). 419–428. 67 indexed citations
17.
18.
Fredenhagen, Andreas, Paul Hug, & HEINRICH H. PETER. (1990). Strobilurins F, G and H, three new antifungal metabolites from Bolinea lutea. II. Structure determination.. The Journal of Antibiotics. 43(6). 661–667. 26 indexed citations
19.
Fredenhagen, Andreas, Susan Y. Tamura, Peter T.M. Kenny, et al.. (1987). Andrimid, a new peptide antibiotic produced by an intracellular bacterial symbiont isolated from a brown planthopper. Journal of the American Chemical Society. 109(14). 4409–4411. 141 indexed citations
20.
Fredenhagen, Andreas & Urs Séquin. (1985). The Structures of Some Products from the Photodegradation of the Pluramycin Antibiotics Hedamycin and Kidamycin. Helvetica Chimica Acta. 68(2). 391–402. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026